journal article·2024-11-14Open access

Spheroid-Exosome-Based Bioprinting Technology in Regenerative Medicine

Hwa-Yong Lee, Jin Woo Lee

Journal of Functional Biomaterials· Volume 15· Issue 11

Abstract

Since the discovery that exosomes can exchange genes, their potential use as tools for tissue regeneration, disease diagnosis, and therapeutic applications has drawn significant attention. Emerging three-dimensional (3D) printing technologies, such as bioprinting, which allows the printing of cells, proteins, DNA, and other biological materials, have demonstrated the potential to create complex body tissues or personalized 3D models. The use of 3D spheroids in bioprinting facilitates volumetric tissue reconstruction and accelerates tissue regeneration via exosome secretion. In this review, we discussed a convergence approach between two promising technologies for bioprinting and exosomes in regenerative medicine. Among the various 3D cell culture methods used for exosome production, we focused on spheroids, which are suitable for mass production by bioprinting. We then summarized the research results on cases of bioprinting applications using the spheroids and exosomes produced. If a large number of spheroids can be supplied through bioprinting, the spheroid-exosome-based bioprinting technology will provide new possibilities for application in tissue regeneration, disease diagnosis, and treatment.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Extracellular vesicles in disease · 3D Printing in Biomedical Research · Tissue Engineering and Regenerative Medicine

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Division of Science Education, Kangwon National University, Chuncheon 24341, Republic of Korea

Department of Molecular Medicine, College of Medicine, Gachon University, Incheon 21999, Republic of Korea

Funding

Korean Fund for Regenerative Medicine · Ministry of Science and ICT, the Ministry of Health and Welfare · National Research Foundation of Korea(NRF) · Gachon University

References (100+)

Show source-provided references
1. Ghasroldasht, M.M., Seok, J., Park, H.S., Ali, F.B.L., and Al-Hendy, A. (2022). Stem cell therapy: From idea to clinical practice. Int. J. Mol. Sci., 23.10.3390/ijms23052850 ↗
2. Stem cell-based therapy for human diseases10.1038/s41392-022-01134-4 ↗
3. Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies10.1038/nm.3267 ↗
4. The biology, function, and biomedical applications of exosomes10.1126/science.aau6977 ↗
5. Extracellular membrane vesicles in the three domains of life and beyond10.1093/femsre/fuy042 ↗
6. Tumor-Derived Exosomes and Their Role in Cancer Progression10.1016/bs.acc.2015.12.005 ↗
7. Techniques for increasing the yield of stem cell-derived exosomes: What factors may be involved?10.1007/s11427-021-1997-2 ↗
8. Rashed, M.H., Bayraktar, E., Helal, G.K., Abd-Ellah, M.F., Amero, P., Chavez-Reyes, A., and Rodriguez-Aguayo, C. (2017). Exosomes: From Garbage Bins to Promising Therapeutic Targets. Int. J. Mol. Sci., 18.10.3390/ijms18030538 ↗
9. Bioprinting of exosomes: Prospects and challenges for clinical applications10.18063/ijb.690 ↗
10. Supermeres are functional extracellular nanoparticles replete with disease biomarkers and therapeutic targets
11. Extracellular vesicles in cardiovascular diseases10.1038/s41420-020-00305-y ↗
12. Kalra, H., Drummen, G.P., and Mathivanan, S. (2016). Focus on extracellular vesicles: Introducing the next small big thing. Int. J. Mol. Sci., 17.10.3390/ijms17020170 ↗
13. The exosome journey: From biogenesis to uptake and intracellular signalling10.1186/s12964-021-00730-1 ↗
14. Regulation of exosome release by glycosphingolipids and flotillins10.1111/febs.12775 ↗
15. Progress in Exosome Isolation Techniques10.7150/thno.18133 ↗
16. Exosomes in the tumor microenvironment as mediators of cancer therapy resistance10.1186/s12943-019-0975-5 ↗
17. Huang, X., Yuan, T., Tschannen, M., Sun, Z., Jacob, H., Du, M., Liang, M., Dittmar, M.R., Liu, Y., and Liang, M. (2013). Characterization of human plasma-derived exosomal RNAs by deep sequencing. BMC Genom., 14.10.1186/1471-2164-14-319 ↗
18. Hade, M.D., Suire, C.N., and Suo, Z. (2021). Mesenchymal stem cell-derived exosomes: Applications in regenerative medicine. Cells, 10.10.3390/cells10081959 ↗
19. Extracellular vesicles as a next-generation drug delivery platform10.1038/s41565-021-00931-2 ↗
20. Ciferri, M., Quarto, R., and Tasso, R. (2021). Extracellular vesicles as biomarkers and therapeutic tools: From pre-clinical to clinical applications. Biology, 10.10.3390/biology10050359 ↗
21. Emerging significance and therapeutic potential of extracellular vesicles10.7150/ijbs.59296 ↗
22. Limongi, T., Susa, F., Dumontel, B., Racca, L., Perrone Donnorso, M., Debellis, D., and Cauda, V. (2021). Extracellular vesicles tropism: A comparative study between passive innate tropism and the active engineered targeting capability of lymphocyte-derived evs. Membranes, 11.10.3390/membranes11110886 ↗
23. Exosomal therapy—A new frontier in regenerative medicine10.21037/sci-2020-037 ↗
24. Fuloria, S., Subramaniyan, V., Dahiya, R., Dahiya, S., Sudhakar, K., Kumari, U., Sathasivam, K., Meenakshi, D., Wu, Y., and Sekar, M. (2021). Mesenchymal stem cell-derived extracellular vesicles: Regenerative potential and challenges. Biology, 10.10.3390/biology10030172 ↗
25. Yin, K., Wang, S., and Zhao, R.C. (2019). Exosomes from mesenchymal stem/stromal cells: A new therapeutic paradigm. Biomark. Res., 7.10.1186/s40364-019-0159-x ↗
26. Mesenchymal stem cell-derived extracellular vesicles promote nerve regeneration after sciatic nerve crush injury in rats
27. Exosome processing and characterization approaches for research and technology development10.1002/advs.202103222 ↗
28. Sumrin, A., Moazzam, S., Khan, A.A., Ramzan, I., Batool, Z., Kaleem, S., Ali, M., Bashir, H., and Bilal, M. (2018). Exosomes as biomarker of cancer. Braz. Arch. Biol. Technol., 61.10.1590/1678-4324-2018160730 ↗
29. Exosomes in cancer development and clinical applications10.1111/cas.13697 ↗
30. Exosomes and their role in cancer progression10.33160/yam.2019.06.002 ↗
31. Li, X., Corbett, A.L., Taatizadeh, E., Tasnim, N., Little, J.P., Garnis, C., Daugaard, M., Guns, E., Hoorfar, M., and Li, I.T.S. (2019). Challenges and opportunities in exosome research—Perspectives from biology, engineering, and cancer therapy. APL Bioeng., 3.10.1063/1.5087122 ↗
32. D’Anca, M., Fenoglio, C., Serpente, M., Arosio, B., Cesari, M., Scarpini, E.A., and Galimberti, D. (2019). Exosome determinants of physiological aging and age-related neurodegenerative diseases. Front. Aging Neurosci., 11.10.3389/fnagi.2019.00232 ↗
33. Dardet, J.P., Serrano, N., András, I.E., and Toborek, M. (2022). Overcoming blood-brain barrier resistance: Implications for extracellular vesicle-mediated drug brain delivery. Front. Drug Deliv., 2.10.3389/fddev.2022.855017 ↗
34. Ebrahimkhani, S., Vafaee, F., Young, P.E., Hur, S.S.J., Hawke, S., Devenney, E., Beadnall, H., Barnett, M.H., Suter, C.M., and Buckland, M.E. (2017). Exosomal microRNA signatures in multiple sclerosis reflect disease status. Sci. Rep., 7.10.1038/s41598-017-14301-3 ↗
35. Garcia-Contreras, M., Shah, S.H., Tamayo, A., Robbins, P.D., Golberg, R.B., Mendez, A.J., and Ricordi, C. (2017). Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes. Sci. Rep., 7.10.1038/s41598-017-05787-y ↗
36. Sun, Y., Tao, Q., Wu, X., Zhang, L., Liu, Q., and Wang, L. (2021). The utility of exosomes in diagnosis and therapy of diabetes mellitus and associated complications. Front. Endocrinol., 12.10.3389/fendo.2021.756581 ↗
37. Engineering exosomes for targeted drug delivery10.7150/thno.52570 ↗
38. Soliman, H.M., Ghonaim, G.A., Gharib, S.M., Chopra, H., Farag, A.K., Hassanin, M.H., Nagah, A., Emad-Eldin, M., Hashem, N.E., and Yahya, G. (2021). Exosomes in alzheimer’s disease: From being pathological players to potential diagnostics and therapeutics. Int. J. Mol. Sci., 22.10.3390/ijms221910794 ↗
39. Presence of Cx43 in extracellular vesicles reduces the cardiotoxicity of the anti-tumour therapeutic approach with doxorubicin10.3402/jev.v5.32538 ↗
40. Engineering macrophage derived exosomes for targeted paclitaxel delivery to pulmonary metastases: In vitro and in vivo evaluations10.1016/j.nano.2017.09.011 ↗
41. Gemcitabine loaded autologous exosomes for effective and safe chemotherapy of pancreatic cancer10.1016/j.actbio.2019.10.022 ↗
42. Dopamine-loaded blood exosomes targeted to brain for better treatment of Parkinson’s disease10.1016/j.jconrel.2018.08.035 ↗
43. Drug delivery with extracellular vesicles: From imagination to innovation10.1021/acs.accounts.9b00109 ↗
44. A novel three step protocol to isolate extracellular vesicles from plasma or cell culture medium with both high yield and purity10.1080/20013078.2020.1791450 ↗
45. Syromiatnikova, V., Prokopeva, A., and Gomzikova, M. (2022). Methods of the large-scale production of extracellular vesicles. Int. J. Mol. Sci., 23.10.3390/ijms231810522 ↗
46. MCF-7 cells as a three-dimensional model for the study of human breast cancer10.1089/ten.tec.2011.0260 ↗
47. Białkowska, K., Komorowski, P., Bryszewska, M., and Miłowska, K. (2020). Spheroids as a type of three-dimensional cell cultures—Examples of methods of preparation and the most important application. Int. J. Mol. Sci., 21.10.3390/ijms21176225 ↗
48. Strategies to enhance extracellular vesicle production10.1007/s13770-021-00364-x ↗
49. Joo, H.S., Suh, J.H., Lee, H.J., Bang, E.S., and Lee, J.M. (2020). Current knowledge and future perspectives on mesenchymal stem cell-derived exosomes as a new therapeutic agent. Int. J. Mol. Sci., 21.10.3390/ijms21030727 ↗
50. Xie, S., Zhang, Q., and Jiang, L. (2022). Current knowledge on exosome biogenesis, cargo-sorting mechanism and therapeutic implications. Membranes, 12.10.3390/membranes12050498 ↗
51. Advances in 3D cell culture technologies enabling tissue-like structures to be created in vitro10.1111/joa.12257 ↗
52. Hydrogels as extracellular matrix mimics for 3D cell culture10.1002/bit.22361 ↗
53. Cellular utilization determines viability and matrix distribution profiles in chondrocyte-seeded alginate constructs10.1089/ten.2004.10.1467 ↗
54. An adaptable hydrogel array format for 3-dimensional cell culture and analysis10.1016/j.biomaterials.2008.04.040 ↗
55. A new technique for studying directional cell migration in a hydrogel-based three-dimensional matrix for tissue engineering model systems10.1016/j.micron.2013.06.002 ↗
56. Yu, W., Li, S., Guan, X., Zhang, N., Xie, X., Zhang, K., and Bai, Y. (2022). Higher yield and enhanced therapeutic effects of exosomes derived from MSCs in hydrogel-assisted 3D culture system for bone regeneration. Biomater. Adv., 133.10.1016/j.msec.2022.112646 ↗
57. Various three-dimensional culture methods and cell types for exosome production10.1007/s13770-023-00551-y ↗
58. Huang, S.W., Tzeng, S.C., Chen, J.K., Sun, J.S., and Lin, F.H. (2020). A dynamic hanging-drop system for mesenchymal stem cell culture. Int. J. Mol. Sci., 21.10.3390/ijms21124298 ↗
59. Three-dimensional spheroid culture increases exosome secretion from mesenchymal stem cells10.1007/s13770-018-0139-5 ↗
60. Giusti, I., Poppa, G., D’Ascenzo, S., Esposito, L., Vitale, A.R., Calvisi, G., and Dolo, V. (2022). Cancer three-dimensional spheroids mimic in vivo tumor features, displaying “inner” extracellular vesicles and vasculogenic mimicry. Int. J. Mol. Sci., 23.10.3390/ijms231911782 ↗
61. Expression of interstitial collagenase is restricted to skeletal tissue during mouse embryogenesis10.1242/jcs.108.2.529 ↗
62. Surface-tension driven open microfluidic platform for hanging droplet culture10.1039/C5LC01353D ↗
63. Three-dimensional cell culture systems as an in vitro platform for cancer and stem cell modeling10.4252/wjsc.v11.i12.1065 ↗
64. Exosomes produced from 3D cultures of MSCs by tangential flow filtration show higher yield and improved activity10.1016/j.ymthe.2018.09.015 ↗
65. Methodological aspects and pharmacological applications of three-dimensional cancer cell cultures and organoids10.1016/j.lfs.2020.117784 ↗
66. Three-dimensional spheroid cell culture of umbilical cord tissue-derived mesenchymal stromal cells leads to enhanced paracrine induction of wound healing10.1186/s13287-015-0082-5 ↗
67. An air bubble- isolating rotating wall vessel bioreactor for improved spheroid/organoid formation10.1089/ten.tec.2019.0088 ↗
68. Monitoring of cell viability and cell growth in a hollow-fiber bioreactor by use of the dye Alamar Blue10.1016/S0022-1759(01)00347-7 ↗
69. Exosomes produced from 3D cultures of umbilical cord mesenchymal stem cells in a hollow-fiber bioreactor show improved osteochondral regeneration activity10.1007/s10565-019-09504-5 ↗
70. Three-dimensional culture of MSCs produces exosomes with improved yield and enhanced therapeutic efficacy for cisplatin-induced acute kidney injury10.1186/s13287-020-01719-2 ↗
71. A review on microwell and microfluidic geometric array fabrication techniques and its potential applications in cellular studies10.1002/cjce.23875 ↗
72. 2D and 3D cell microarrays in pharmacology10.1016/j.coph.2009.05.002 ↗
73. Three-dimensional culture of dental pulp pluripotent-like stem cells (DPPSCs) enhances Nanog expression and provides a serum-free condition for exosome isolation10.1096/fba.2020-00025 ↗
74. Defined serum-free three-dimensional culture of umbilical cord-derived mesenchymal stem cells yields exosomes that promote fibroblast proliferation and migration in vitro10.1096/fj.202001768RR ↗
75. Manipulating magnetic 3D spheroids in hanging drops for applications in tissue engineering and drug screening10.1002/adhm.201200408 ↗
76. Manipulation of cellular spheroid composition and the effects on vascular tissue fusion10.1016/j.actbio.2014.11.024 ↗
77. Biological magnetic cellular spheroids as building blocks for tissue engineering10.1016/j.actbio.2013.10.021 ↗
78. Janus magnetic cellular spheroids for vascular tissue engineering10.1016/j.biomaterials.2013.10.036 ↗
79. Magnetically levitated mesenchymal stem cell spheroids cultured with a collagen gel maintain phenotype and quiescence10.1177/2041731417704428 ↗
80. Generation and manipulation of magnetic multicellular spheroids10.1016/j.biomaterials.2009.12.047 ↗
81. Magnetic manipulation and spatial patterning of multi-cellular stem cell aggregates10.1039/c1ib00064k ↗
82. Cell-patterning using poly (ethylene glycol)-modified magnetite nanoparticles
83. High-precision 3D bio-dot printing to Improve paracrine interaction between multiple types of cell spheroids10.1002/adfm.202005324 ↗
84. Park, Y., Ji, S.T., Yong, U., Das, S., Jang, W.B., Ahn, G., Kwon, S.M., and Jang, J. (2021). 3D bioprinted tissue-specific spheroidal multicellular microarchitectures for advanced cell therapy. Biofabrication, 13.10.1088/1758-5090/ac212e ↗
85. Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer10.1038/mt.2008.1 ↗
86. Livshits, M.A., Khomyakova, E., Evtushenko, E.G., Lazarev, V.N., Kulemin, N.A., Semina, S.E., Generozov, E.V., and Govorun, V.M. (2015). Isolation of exosomes by differential centrifugation: Theoretical analysis of a commonly used protocol. Sci. Rep., 5.10.1038/srep17319 ↗
87. Isolation and characterization of exosomes from cell culture supernatants and biological fluids
88. New insight into isolation, identification techniques and medical applications of exosomes10.1016/j.jconrel.2019.07.021 ↗
89. Single-step isolation of extracellular vesicles by size-exclusion chromatography10.3402/jev.v3.23430 ↗
90. Exosome: A review of its classification, isolation techniques, storage, diagnostic and targeted therapy applications10.2147/IJN.S264498 ↗
91. Integrated isolation and quantitative analysis of exosome shuttled proteins and nucleic acids using immunocapture approaches10.1016/j.ymeth.2015.05.028 ↗
92. Preservation techniques of stem cells extracellular vesicles: A gate for manufacturing of clinical grade therapeutic extracellular vesicles and long-term clinical trials10.1080/23144599.2019.1704992 ↗
93. Preservation and storage stability of extracellular vesicles for therapeutic applications10.1208/s12248-017-0160-y ↗
94. Kusuma, G.D., Barabadi, M., Tan, J.L., Morton, D.A.V., Frith, J.E., and To, L.R. (2018). Protect and to preserve: Novel preservation strategies for extracellular vesicles. Front. Pharmacol., 9.10.3389/fphar.2018.01199 ↗
95. Exosomes: Improved methods to characterize their morphology, RNA content, and surface protein biomarkers10.1039/C5AN00688K ↗
96. Bosch, S., de Beaurepaire, L., Allard, M., Mosser, M., Heichette, C., Chrétien, D., Jegou, D., and Bach, J.M. (2016). Trehalose prevents aggregation of exosomes and cryodamage. Sci. Rep., 6.10.1038/srep36162 ↗
97. Preservation of exosomes at room temperature using lyophilization10.1016/j.ijpharm.2018.10.032 ↗
98. Effect of storage on physical and functional properties of extracellular vesicles derived from neutrophilic granulocytes10.3402/jev.v3.25465 ↗
99. Lee, H.-W., and Lee, J.W. (2023). Current status and future outlook of additive manufacturing technologies for the reconstruction of the trachea. J. Funct. Biomater., 14.10.3390/jfb14040196 ↗
100. Genova, T., Roato, I., Carossa, M., Motta, C., Cavagnetto, D., and Mussano, F. (2020). Advances on Bone Substitutes through 3D Bioprinting. Int. J. Mol. Sci., 21.10.3390/ijms21197012 ↗